Cemiplimab Shows Promise for Patients with Advanced Basal Cell Carcinoma

Cemiplimab showed clinically meaningful and durable responses in this group of patients for whom there are no currently approved treatments.

Source: CancerNetwork - May 6, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news